Richard C Boucher Selected Research

Luciferases

1/2020

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard C Boucher Research Topics

Disease

58	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 02/2002
31	Inflammation (Inflammations) 11/2023 - 09/2002
30	Lung Diseases (Lung Disease) 11/2023 - 11/2003
22	Infections 11/2023 - 12/2004
17	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 04/2008
14	COVID-19 11/2023 - 01/2020
7	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018 - 11/2008
6	Asthma (Bronchial Asthma) 01/2022 - 01/2005
6	Chronic Bronchitis 01/2017 - 07/2006
5	Bacterial Infections (Bacterial Infection) 01/2014 - 04/2003
4	Chronic Disease (Chronic Diseases) 12/2022 - 12/2008
4	Bronchiectasis 01/2022 - 12/2016
4	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 11/2018 - 05/2002
4	Dehydration (Water Stress) 02/2012 - 11/2004
4	Metaplasia 02/2012 - 04/2008
3	Hypoxia (Hypoxemia) 11/2023 - 02/2002
3	Pneumonia (Pneumonitis) 11/2023 - 06/2007
3	Idiopathic Pulmonary Fibrosis 11/2023 - 01/2019
3	Airway Obstruction (Choking) 12/2018 - 05/2004
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2022 - 11/2020
2	Tertiary Lymphoid Structures 02/2022 - 01/2022
2	Pseudohypoaldosteronism 01/2018 - 01/2003
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2006 - 05/2005
1	Pathologic Dilatation (Ectasia) 11/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Fever (Fevers) 11/2023

Drug/Important Bio-Agent (IBA)

27	MucinsIBA 11/2023 - 11/2004
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2009
13	Adenosine Triphosphate (ATP)IBA 01/2022 - 05/2003
12	CytokinesIBA 11/2023 - 09/2002
11	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 04/2003
7	Amiloride (Midamor)FDA LinkGeneric 12/2008 - 01/2003
6	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2020
6	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2023 - 01/2004
6	Epithelial Sodium ChannelsIBA 01/2018 - 12/2004
5	NucleotidesIBA 01/2017 - 08/2003
5	Chloride Channels (Chloride Channel)IBA 01/2011 - 09/2002
4	Phenobarbital (Luminal)FDA Link 01/2023 - 03/2005
4	SmokeIBA 01/2023 - 02/2012
4	Antiviral Agents (Antivirals)IBA 02/2022 - 05/2021
4	Angiotensin-Converting Enzyme 2IBA 01/2022 - 01/2020
4	Urea (Carbamide)FDA LinkGeneric 01/2017 - 06/2009
4	SodiumIBA 01/2016 - 06/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2012 - 02/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 09/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2003
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2022
3	Interleukin-13IBA 01/2022 - 04/2008
3	Messenger RNA (mRNA)IBA 12/2020 - 10/2012
3	Mucin-5BIBA 01/2019 - 11/2018
3	PurinesIBA 12/2016 - 06/2009
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 04/2013 - 01/2006
3	Adenosine Monophosphate (AMP)IBA 10/2011 - 08/2004
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2023 - 02/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2019
2	LigandsIBA 12/2022 - 01/2005
2	Expectorants (Mucolytics)IBA 12/2022 - 01/2019
2	CollagenIBA 02/2022 - 01/2022
2	nintedanibIBA 02/2022 - 01/2022
2	molnupiravirIBA 02/2022 - 01/2022
2	AerosolsIBA 01/2022 - 07/2006
2	Mucin 5ACIBA 01/2022 - 01/2019
2	GoldIBA 01/2022 - 10/2011
2	Detergents (Detergent)IBA 01/2022 - 05/2021
2	Surface-Active Agents (Surfactants)IBA 12/2020 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 12/2020 - 01/2018
2	Ion Channels (Ion Channel)IBA 01/2018 - 01/2013
2	EnzymesIBA 12/2016 - 12/2015
2	purineIBA 08/2015 - 06/2009
2	Phenylalanine (L-Phenylalanine)FDA Link 04/2013 - 10/2011
2	Sodium Channels (Sodium Channel)IBA 04/2012 - 11/2007
2	Cyclic AMP (AMP, Cyclic)IBA 06/2009 - 08/2004
2	ChitinasesIBA 04/2009 - 04/2008
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2005 - 08/2004
1	InterleukinsIBA 11/2023
1	CotinineIBA 01/2023
1	Nicotine FDA Link 01/2023
1	Viral RNAIBA 01/2023
1	hydroxycotinineIBA 01/2023
1	InflammasomesIBA 01/2023
1	Periodic AcidIBA 12/2022
1	Alcian BlueIBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Peptide Hydrolases (Proteases)FDA Link 03/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2022
1	tocilizumab (atlizumab)FDA Link 03/2022
1	Reducing AgentsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	P-2165IBA 01/2022
1	Sulfhydryl Compounds (Thiols)IBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Proline (L-Proline)FDA Link 01/2022
1	(2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA 01/2022

Therapy/Procedure

32	Therapeutics 11/2023 - 11/2003
2	Drug Therapy (Chemotherapy) 01/2020 - 06/2008
2	Fluid Therapy (Oral Rehydration Therapy) 09/2013 - 01/2007
1	Heterologous Transplantation (Xenotransplantation) 11/2023
1	Lung Transplantation 11/2023